Tweet
Does anyone have experience using the QIAXCEL to QC libraries? If you could tell me any of the pros or cons of using it I would greatly appreciate it. We'll most likely be using Nextera Kits and running on the MiSeq.
-
-
I plan to, and I am also searching for some one experenced in itOriginally posted by Vanschkn View Post
.
-
QiaXcel compared to Bioanalyzer?
Hello,
I am new to QiaXcel, and I wonder anybody have compared the results between QiaXcel and Bioanalyzer?
Thanks in advance!Comment
-
QIAxcel can run libraries for QC, size and concentration
I work as an applications scientist at QIAGEN, and I frequently run libraries on the QIAxcel. Nextera, QIAseq, etc - as long as there was a PCR step during library prep, the QIAxcel can analyze it. I've even started with concentrations <0.1ng/ul.
It's a user-developed application (for now), meaning we have clear instructions how to generate good data, but you'll have to ask someone like your regional sales rep or applications scientist. If you don't know your Q contact, call 1-800-DNA-PREP.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment